Adage Capital Partners Gp, L.L.C. Sutro Biopharma, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,000,000 shares of STRO stock, worth $8.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 4,467,796
55.24%
Holding current value
$8.44 Million
Previous $19.2 Million
41.04%
% of portfolio
0.02%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding STRO
# of Institutions
123Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$24.4 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$24.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$20 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$17.3 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$12.8 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $220M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...